Anti-resorptive approaches such as administration of bisphosphonates or anti-PTHrP neutralizing antibody have been reported in breast cancer models to be able to block the tumor expansion in bone (Guise et al. 1996; Sasaki et al. 1995). Here, PTHLH is linked to breast carcinoma.